Predictive factors for early super response to bimekizumab in 341 patients with psoriasis—a 24-week short-term multicenter real-life experience

Tubanur Çetinarslan, Muhammed Ali Mergen, Aylin Türel Ermertcan, Emel Bülbül Başkan, Serkan Yazıcı, İsa An, Gülhan Gürel, Esra Adışen, Abdullah Demirbaş, Recep Dursun, Bahadır Aslancan, Zeynep Topkarcı, Mustafa Esen, Zafer Türkoğlu, Dilek Canat, Selim Kandiş, Arzu Kılıç, İlgen Ertam Sağduyu, Elif Irmak Yazıcı, Ece Gökyayla, Neslihan Demirel Öğüt, Özge Sevil Karstarlı Bakay, Selami Aykut Temiz, Vefa Aslı Erdemir, Fatma Aslı Hapa, Ömer Aydin, Pelin Hızlı, Berna Solak, Melike Bütüner, Sema Aytekin, Hülya Albayrak, Munise Daye, Ümit Türsen, Ayşe Nur Sarıbaş Yıldırım, Beyhan Cengiz Özyurt

Open source

DOI: 10.1080/09546634.2025.2563657
Published: 2025-10
Container: Journal of Dermatological Treatment
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/09546634.2025.2563657,
  title = {Predictive factors for early super response to bimekizumab in 341 patients with psoriasis—a 24-week short-term multicenter real-life experience},
  author = {Tubanur Çetinarslan and Muhammed Ali Mergen and Aylin Türel Ermertcan and Emel Bülbül Başkan and Serkan Yazıcı and İsa An and Gülhan Gürel and Esra Adışen and Abdullah Demirbaş and Recep Dursun and Bahadır Aslancan and Zeynep Topkarcı and Mustafa Esen and Zafer Türkoğlu and Dilek Canat and Selim Kandiş and Arzu Kılıç and İlgen Ertam Sağduyu and Elif Irmak Yazıcı and Ece Gökyayla and Neslihan Demirel Öğüt and Özge Sevil Karstarlı Bakay and Selami Aykut Temiz and Vefa Aslı Erdemir and Fatma Aslı Hapa and Ömer Aydin and Pelin Hızlı and Berna Solak and Melike Bütüner and Sema Aytekin and Hülya Albayrak and Munise Daye and Ümit Türsen and Ayşe Nur Sarıbaş Yıldırım and Beyhan Cengiz Özyurt},
  year = {2025},
  journal = {Journal of Dermatological Treatment},
  doi = {10.1080/09546634.2025.2563657},
  url = {https://doi.org/10.1080/09546634.2025.2563657}
}

RIS

TY  - JOUR
TI  - Predictive factors for early super response to bimekizumab in 341 patients with psoriasis—a 24-week short-term multicenter real-life experience
AU  - Tubanur Çetinarslan
AU  - Muhammed Ali Mergen
AU  - Aylin Türel Ermertcan
AU  - Emel Bülbül Başkan
AU  - Serkan Yazıcı
AU  - İsa An
AU  - Gülhan Gürel
AU  - Esra Adışen
AU  - Abdullah Demirbaş
AU  - Recep Dursun
AU  - Bahadır Aslancan
AU  - Zeynep Topkarcı
AU  - Mustafa Esen
AU  - Zafer Türkoğlu
AU  - Dilek Canat
AU  - Selim Kandiş
AU  - Arzu Kılıç
AU  - İlgen Ertam Sağduyu
AU  - Elif Irmak Yazıcı
AU  - Ece Gökyayla
AU  - Neslihan Demirel Öğüt
AU  - Özge Sevil Karstarlı Bakay
AU  - Selami Aykut Temiz
AU  - Vefa Aslı Erdemir
AU  - Fatma Aslı Hapa
AU  - Ömer Aydin
AU  - Pelin Hızlı
AU  - Berna Solak
AU  - Melike Bütüner
AU  - Sema Aytekin
AU  - Hülya Albayrak
AU  - Munise Daye
AU  - Ümit Türsen
AU  - Ayşe Nur Sarıbaş Yıldırım
AU  - Beyhan Cengiz Özyurt
PY  - 2025
JO  - Journal of Dermatological Treatment
DO  - 10.1080/09546634.2025.2563657
UR  - https://doi.org/10.1080/09546634.2025.2563657
ER  -

APA

Çetinarslan, T., Mergen, M. A., Ermertcan, A. T., Başkan, E. B., Yazıcı, S., An, İ., Gürel, G., Adışen, E., Demirbaş, A., Dursun, R., Aslancan, B., Topkarcı, Z., Esen, M., Türkoğlu, Z., Canat, D., Kandiş, S., Kılıç, A., Sağduyu, İ. E., Yazıcı, E. I., Gökyayla, E., Öğüt, N. D., Bakay, Ö. S. K., Temiz, S. A., Erdemir, V. A., Hapa, F. A., Aydin, Ö., Hızlı, P., Solak, B., Bütüner, M., Aytekin, S., Albayrak, H., Daye, M., Türsen, Ü., Yıldırım, A. N. S., & Özyurt, B. C. (2025). Predictive factors for early super response to bimekizumab in 341 patients with psoriasis—a 24-week short-term multicenter real-life experience. Journal of Dermatological Treatment. https://doi.org/10.1080/09546634.2025.2563657

Source records

crossref · retrieved 2026-09-27T14:36:28.767Z